EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Polygenic risk score of Alzheimer's disease is associated with cognitive trajectories and phenotypes of cerebral organoids

Min Young Chun, Sang-Hyuk Jung, Juran Choe, Seung-Yeon Lee, Hang-Rai Kim, Hyo Jin Son, Yejoo Choi, Minyoung Cho, Beomsu Kim, Hyemin Jang, Seong Hye Choi, Jee Hyang Jeong und 8 weitere

Alzheimer's & Dementia · 2025-09 · 21 (9)

DOI: 10.1002/alz.70660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 17.09.2025. Verfasst von Min Young Chun und 19 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Organoids, Multifactorial Inheritance, Cognitive Dysfunction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Technology R&D Project, Korea Health Industry Development Institute, Ministry of Health and Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Polygenic risk score (PRS) identifies individuals at high genetic risk for Alzheimer's disease (AD), but its utility in predicting cognitive trajectories and AD pathologies remains unclear. We optimized PRS (optPRS) for AD, investigated its association with cognitive trajectories and AD phenotypes of cerebral organoids. METHODS Using genome‐wide association study (GWAS) summary statistics from a European population, we developed optPRS to predict AD in Korean individuals (n = 1634). We analyzed the association between optPRS and cognitive trajectories (n = 771). We generated induced pluripotent stem cell–derived cerebral organoids from patients with high (n = 3) and low (n = 4) optPRS to evaluate amyloid beta (Aβ) and phosphorylated tau (p‐tau) levels. RESULTS OptPRS predicted AD dementia and Aβ positivity, independent of apolipoprotein E ( APOE ). Higher optPRSs correlated with rapid cognitive decline. Cerebral organoids from the high optPRS group exhibited increased Aβ insolubility and p‐tau levels. CONCLUSION OptPRS predicted cognitive decline and AD phenotypes of cerebral organoids, supporting its use in risk assessments and drug‐screening platform. Highlights Optimized polygenic risk scores (optPRSs) improve the prediction of Alzheimer's disease (AD) dementia and amyloid beta positivity (Aβ+). High optPRS is associated with faster cognitive decline, particularly in Aβ+. Induced pluripotent stem cell (iPSC)–derived cerebral organoids from high optPRSs show high Aβ insolubility and phosphorylated tau (p‐tau). PRS genetic risk stratification provides insight into AD progression and pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseOrganoidsMultifactorial InheritanceCognitive DysfunctionHumansGenome-Wide Association StudyPhenotypeAmyloid beta-Peptidestau ProteinsMaleFemaleAgedInduced Pluripotent Stem CellsGenetic Predisposition to DiseaseCognitionGenetic Risk Score

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid betacognitive trajectoryorganoidsphosphorylated taupolygenic risk score

Substanzen

Amyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Departments of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, South Korea.
  • Department of Medical Informatics, Kangwon National University College of Medicine, Chuncheon, South Korea.
  • Department of Brain Sciences, Daegu Gyeongbuk Institute of Science & Technology, Daegu, South Korea.
  • Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.

Förderung

  • Korea Health Technology R&D Project
  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare, Republic of Korea
  • Future Medicine 2030 Project of the Samsung Medical Center
  • National Research Foundation of Korea
  • ICT Creative Consilience Program
  • Institute of Information & Communications Technology Planning & Evaluation
  • Korea government (MSIT)

Zitieren

APA

Chun, M. Y., Jung, S. H., Choe, J., Lee, S. Y., Kim, H. R., Son, H. J., Choi, Y., Cho, M., Kim, B., Jang, H., Choi, S. H., Jeong, J. H., Son, S. J., Hong, C. H., Roh, H. W., Na, D. L., Seo, S. W., Won, H. H., Seo, J., & Kim, H. J. (2025). Polygenic risk score of Alzheimer's disease is associated with cognitive trajectories and phenotypes of cerebral organoids. Alzheimer's & Dementia, 21(9). https://doi.org/10.1002/alz.70660

Vancouver

Chun MY, Jung SH, Choe J, Lee SY, Kim HR, Son HJ, et al. Polygenic risk score of Alzheimer's disease is associated with cognitive trajectories and phenotypes of cerebral organoids. Alzheimer's & Dementia. 2025;21(9). doi:10.1002/alz.70660

BibTeX
@article{Chun2025,
  author = {Chun, Min Young and Jung, Sang-Hyuk and Choe, Juran and Lee, Seung-Yeon and Kim, Hang-Rai and Son, Hyo Jin and Choi, Yejoo and Cho, Minyoung and Kim, Beomsu and Jang, Hyemin and Choi, Seong Hye and Jeong, Jee Hyang and Son, Sang Joon and Hong, Chang Hyung and Roh, Hyun Woong and Na, Duk L and Seo, Sang Won and Won, Hong-Hee and Seo, Jinsoo and Kim, Hee Jin},
  title = {Polygenic risk score of Alzheimer's disease is associated with cognitive trajectories and phenotypes of cerebral organoids},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {9},
  doi = {10.1002/alz.70660}
}
Kostenlos starten →